PreviPharma COVID-19 Statement
To our customers and partners,
In the current global situation caused by COVID-19, PreviPharma is committed to keeping you informed of our actions to provide important services to our global customers and partners.
⬝ As member of the global community, we take precautions with safety first
⬝ We follow the recommendations of the World Health Organization (WHO) to reduce the spread of COVID-19
⬝ We follow instructions from the German government and Robert Koch Institute (RKI) on how to handle COVID-19 and take precautions to ensure the health of our team
⬝ Our entire operations and laboratory structure comply with local guidelines such as home-based work and physical distance and these measures have no impact on our research projects, customer service projects, and cooperation projects
⬝ If a country orders the closure of supplier or partner companies in a region for an extended period of time, PreviPharma operations might be affected. However, we will do everything we can to avoid supply shortage e.g. through alternative suppliers
PreviPharma will continue to act with the utmost urgency to support our customers and to advance scientific research and improvement of healthcare.